Structural and functional basis for JAK3-deficient severe combined immunodeficiency

Blood

Volumn 90, Issue 10, 1997, Pages 3996-4003

  Candotti, Fabio ^b   Oakes, Scott A ^b   Johnston, James A ^b   Giliani, Silvia ^b   Schumacher, Richard F ^b   Mella, Patrizia ^b   Fiorini, Maurilia ^b   Ugazio, Alberto G ^b   Badolato, Raffaele ^b   Notarangelo, Luigi D ^b   Bozzi, Fabio ^b   Macchi, Paolo ^b   Strina, Dario ^b   Vezzoni, Paolo ^b   Blaese, R Michael ^b   O'Shea, John J ^b   Villa, Anna ^a  

^a CNR   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 4; PROTEIN TYROSINE KINASE;

AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; COMBINED IMMUNODEFICIENCY; GENE DELETION; GENETIC DISORDER; HUMAN; HUMAN CELL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 0030729823     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.10.3996     Document Type: Article

References (31)

1. Taniguchi T: Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268:251, 1995
2. Ihle JN: Cytokine receptor signalling. Nature 377:591, 1995
3. Darnell JE, Schindler C: Transcriptional responses to polypeptide ligands: The JAKs-Stat pathway. Annu Rev Biochem 64:621, 1995
4. Kawamura M, McVicar DW, Johnston JA, Blake TB, Chen YQ, Lal BK, Lloyd AR, Kelvin DJ, Staples JE, Ortaldo JR, O'Shea JJ: Molecular cloning of L-Jak, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes. Proc Natl Acad Sci USA 91:6374, 1994
5. Johnston JA, Kawamura M, Kirken RA, Chen YQ, Blake TB, Shibuya K, Ortaldo JR, McVicar DW, O'Shea J: Phosphorylation and activation of the jak3 janus kinase in response to interleukin 2. Nature 370:151, 1994
6. Witthuhn BA, Silvennoinen O, Miura O, Lai KS, Cwick C, Liu ET, Ihle JN: Involvement of the Jak-3 Janus kinase in signaling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 370:153, 1994
7. Macchi P, Villa A, Giliani S, Sacco MG, Frattini A, Porta F, Ugazio AG, Johnston JA, Candotti F, O'Shea JJ, Vezzoni P, Notarangelo LD: Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377:65, 1995
8. Russell SM, Tayebi H, Nakajima MC, Riedy MC, Roberts JL, Aman MJ, Migone TS, Noguchi M, Marken ML, Buckley RH, O'Shea JJ, Leonard WJ: Mutation of jak3 in a patient with SCID: Essential role of jak3 in lymphoid development. Science 270:797, 1995
9. Nosaka T, van Deursen JM, Tripp RA, Thierfelder WE, Witthuhn BA, McMickle AP, Doherty PC, Grosveld GC, Ihle JN: Defective lymphoid development in mice lacking jak3. Science 270:800, 1995
10. Thomis DC, Gurniak CB, Tivol E, Sharpe AH, Berg LJ: Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking jak3. Science 270:794, 1995
11. Park SJ, Saijo K, Takahashi O, Arase N, Hirayama N, Miyake K, Nakauchi H, Shirasawa T, Saito T: Developmental defects of lymphoid cells in jak3 kinase-deficient mice. Immunity 3:771, 1995
12. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
13. Feinberg A, Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6, 1983
14. Villa A, Sironi M, Macchi P, Matteucci C, Notarangelo LD, Vezzoni P, Mantovani A: Monocyte function in a SCID patient with a donor splice site mutation in the jak3 gene. Blood 88:817, 1996
15. Wengler GS, Notarangelo LD, Berardelli S, Pollonini G, Mella P, Fasth A, Ugazio AG, Parolini O: High prevalence of nonsense, frame shift, and splice-site mutations in 16 patients with full-blown Wiskott-Aldrich syndrome. Blood 86:3648, 1996
16. Liu X, Robinson GW, Gouilleux F, Groner B, Hennighausen L: Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammry tissue. Proc Natl Acad Sci USA 92:8831, 1995
17. Oakes SA, Candotti F, Johnston JA, Chen Y-Q, Ryan JJ, Taylor N, Liu X, Hennighausen L, Notarangelo LD, Paul WE, Blaese RM, O'Shea JJ: Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and -independent pathways. Immunity 5:605, 1996
18. Maquat LE: Defects in RNA splicing and the consequence of shortened translational reading frames. Am J Hum Genet 59:279, 1996
19. Candotti F, Oakes S, Johnston J, Notarangelo L, O'Shea JJ, Blaese M: In vitro correction of jak 3 deficient severe combined immunodeficiency by retroviral-mediated gene transduction. J Exp Med 183:2687, 1996
20. Morelon E, Dautry-Varsat A, Le Deist F, Hacei-Bay S, Fischer A, de Saint Basile G: T lymphocyte differentiation and proliferation in the absence of the cytoplasmic tail of the common cytokine receptor gamma chain in a SCIDX1 patient. Blood 89:1708, 1996
21. 20a. Taylor N, Candotti F, Smith S, Oakes SA, John T, Isakov J, Puck JM, O'Shea JJ, Weinberg K, Johnston JA: Interleukin-4 signaling in B lymphocytes from patients with X-linked severe combined immunodeficiency. J Biol Chem 272: 7314, 1997
22. Matthews DJ, Clark PA, Herbert J, Morgan G, Armitage RJ, Kinnon C, Minty A, Grabstein KH, Caput D, Ferrara P, Callard R: Function of the interleukin-2 (IL-2) receptor γ-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15. Blood 85:38, 1995
23. Izuhara K, Heike T, Otsuka T, Yamaoka K, Mayumi M, Imamura T, Nibo Y, Harada N: Signal transduction pathway of interleukin-4 and interleukin-13 in human B cells derived from X-linked severe combined immunodeficiency patients. J Biol Chem 271:619, 1996
24. Murata T, Noguchi PD, Puri R: Receptors for interleukin (IL)-4 do not associate with the common chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells. J Biol Chem 270:30829, 1995
25. Obiri NI, Debinski W, Leonard WJ, Puri RK: Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common gamma chain shared by receptors for interleukins 2, 4, 7, 9, and 15. J Biol Chem 270:8797, 1995
26. Murata T, Noguchi PD, Puri RK: IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: Similarities between IL-4 and IL-13 signaling. J Immunol 156:2972, 1996
27. Schnyder B, Lugli S, Feng N, Etter H, Lutz RA, Ryffel B, Sugamura K, Wunderli-Allenspach H, Moser R: Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common γ-chain. Blood 87:4286, 1996
28. Palmer-Crocker RL, Hughes CCW, Prober JS: IL-4 and IL-13 activate the JAK2 tyrosine kinase and STAT6 in cultured human vascular endothelial cells through a common pathway that does not involve the chain. J Clin Invest 98:604, 1996
29. Hilton DJ, Zhang JG, Metcalf D, Alexander WS, Nicola NA, Willson TA: Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci USA 93:497, 1996
30. Caput D, Laurent P, Kaghad M, Lelias J-M, Lefort S, Vita N, Ferrara P: Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor α chain. J Biol Chem 271:16921, 1996
31. Lai SY, Molden J, Liu KD, Puck JM, White MD, Goldsmith MA: Interleukin-4 specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor alpha subunit. EMBO J 15:4506, 1996